IL-17A producing mast cells as therapeutic target in spondyloarthritis by Canete J, Tak P P, Noordenbos T, Gofita I, Yeremenko N, Baeten D

IL-17 producing mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis by Noordenbos Troy, Yeremenko Nataliya, Gofita Ioana, Tak Paul Peter, Cañete Juan, Baeten Dominique

Variation in practice and outcomes after inguinal hernia repair: a nationwide observational study by Carmen S. S. Latenstein, Floris M. Thunnissen, Mitchell Harker, Stef Groenewoud, Mark W. Noordenbos, Femke Atsma, Philip R. de Reuver

Get full text

A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis by Jacqueline E. Paramarta, Maureen C. Turina, Troy Noordenbos, Tanja F. Heijda, Iris C. Blijdorp, Nataliya Yeremenko, Dominique Baeten

Get full text

Impact of evidence-based guidelines on healthcare utilisation and costs for disc related sciatica in the Netherlands: a population-based, cross-sectional study by Wilbert B van den Hout, Wilco Peul, Wouter A Moojen, Peter Paul van Benthem, Juliëtte van Munster, Mark W Noordenbos, I J Y Halperin, Ingrid Seinen

Get full text